Receptor-selective mutants of tumour necrosis factor in the therapy of cancer: Preclinical studies

Circulatory Shock

Volumn 43, Issue 4, 1994, Pages 185-190

  Brouckaert, P ^a   Ameloot, P ^a   Cauwels, A ^a   Everaerdt, B ^a   Libert, C ^a   Takahashi, N ^a   Van Molle, W ^a   Fiers, W ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

1 acid glycoprotein; Bacillus Calmette Guerin; interferon ; interleukin 6; LFA 1; pharmacokinetics; tolerance

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; OROSOMUCOID; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER; DRUG TOLERANCE; HALF LIFE TIME; LETHALITY; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; TOXICITY;

ANIMAL; DRUG TOLERANCE; MUTATION; NEOPLASMS, EXPERIMENTAL; RECEPTORS, TUMOR NECROSIS FACTOR; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR;

EID: 0028610050     PISSN: 00926213     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)